Immunohistological Evaluation of Mhc Class I And Ii Antigen Expression on Nevi and Melanoma: Relation to Biology of Melanoma

References

• Giles R C, Capra JD. Biochemistry of MHC class II molecules. Tissue Antigens 1985; 25: 57–68
   Google Scholar
• Natali P G, Bigotti A, Nicotra M R, et al. Distribution of human class I (HLA-A, B, C) histocompatibility antigens in normal and malignant tissues of non-lymphoid origin. Canc Res 1984; 44: 4679–87
   PubMed Web of Science ®Google Scholar
• Doherty P C, Blanden R V, Zinkernagel RM. Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: Implications for H-2 antigen diversity. Transplant Rev 1976; 29: 90–124
   Google Scholar
• Lanzavecchia A. Ag-specific interaction between T and B cells. Nature 1985; 314: 537–9
   PubMed Web of Science ®Google Scholar
• Thorsby E. The role of HLA in T cell activation. Hum Immunol 1984; 9: 1–7
   PubMed Web of Science ®Google Scholar
• Palacios R. Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins. Immunol Rev 1982; 63: 73–110
   PubMed Web of Science ®Google Scholar
• Zehngebot L M, Alexander M A, Guerry D, IV, et al. Functional consequence of variation in melanoma antigen expression. Canc Immunol lmmunother 1983; 16: 30–4
   Google Scholar
• Guerry D, Alexander M A, Herlyn M F, et al. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. J Clin Invest 1984; 73: 267–71
   PubMed Web of Science ®Google Scholar
• Fossati G, Taramelli D, Balsari A, et al. Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes. Int J Cancer 1984; 33: 591–7
   PubMed Web of Science ®Google Scholar
• Ruiter D J, Bergman W, Welvaart K, et al. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. Canc Res 1984; 44: 3930–5
   PubMed Web of Science ®Google Scholar
• Ruiter D J, Van Duinen S G, Brocker E B, Ferrone S. Expression of major histocompatibility complex (MHC) antigens in melanocytes, nevocellular nevi and malignant melanomas. Proc Roy Coll Pathol 1985; 17: 21, abstract
   Google Scholar
• Natali P G, Bigotti A, Cavaliere R, et al. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. J Natl Canc Inst 1984; 73: 13–24
   Google Scholar
• Ruiter D J, Bhan A K, Horrist T J, et al. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol 1982; 129: 2808–15
   PubMedGoogle Scholar
• Brocker E B, Suter L, Sorg C. HLA-DR antigen expression in primary melanomas of the skin. J Invest Dermatol 1984; 82: 244–7
   PubMed Web of Science ®Google Scholar
• Ernstoff M C, Duray P, Stenn K, Kirkwood JM. Antigenic phenotype of pigment cell lesions: A study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma. J Invest Dermatol 1985; 84: 430–2
   Google Scholar
• Taramelli D, Fossati G, Mazzocchi A, et al. Classes I and II HLA and melanoma associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Canc Res 1986; 46: 433–9
   PubMedGoogle Scholar
• Pollack M S, Chin-Louie J, Moshief RD. Functional characteristics and differential expression of class II DR, DS and SB antigens on human melanoma cell lines. Hum lmmunol 1984; 9: 75–87
   PubMed Web of Science ®Google Scholar
• Hsu S M, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am SOC Clin Pathol 1981; 75: 734–8
   PubMed Web of Science ®Google Scholar
• Hersey P, Grace J, Murray E, Palmer A, McCarthy WH. Expression of Thy-1 antigen on human melanoma cells. Int J Cancer 1983; 32: 21–5
   Google Scholar
• Hersey P, Murray E, Grace J, McCarthy WH. Current research on immunopathology of melanoma: Analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma. Pathology 1985; 17: 385–91
   PubMed Web of Science ®Google Scholar
• Bradstock K, Hewson J, Kerr A, et al. Expression of terminal deoxynucleotidyl transferase in myeloblasts. Am J Clin Path 1983; 80: 800–5
   Google Scholar
• Brodsky FM. A matrix approach to human class II histocompatibility antigens: Reactions of four monoclonal antibodies with the products of nine haplotypes. Lmmunogenetics 1984; 19: 179
   PubMedGoogle Scholar
• Seigel S. Non-parametric statistics for the behavioural sciences. McGraw-Hill, USA 1956
   Google Scholar
• Brocker E B, Suter L, Bruggen J, et al. Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer 1985; 36: 29–35
   PubMed Web of Science ®Google Scholar
• McGovern V J, Shaw H M, Milton G W, Farago GA. Prognostic significance of the histological features of malignant melanoma. Histopathology 1979; 3: 385–94
   Google Scholar
• Ljunggren H G, Karre K. Host resistance directed selectively against H2 deficient lymphoma variants. Analysis of the mechanism. J Exp Med 1985; 162: 1745–59
   PubMed Web of Science ®Google Scholar
• Hersey P, Edwards A, Milton G W, McCarthy WH. No evidence for an association between natural killer cell activity and prognosis in melanoma patients. Natural lmmun Cell Growth Reg 1983/1984; 3: 87–94
   Google Scholar
• Wang C Y, AI-Katib A, Lane C L, et al. Induction of HLA-DL/DS (Leu 10) antigen expression by human precursor B cell lines. J Exp Med 1983; 158: 1757–62
   PubMedGoogle Scholar
• Holzmann B, Johnson J P, Kaudewitz P, Reithmuller G. In-situ analysis of antigens on malignant and benign cells of the melanocyte lineage: Differential expression of two surface molecules. J Exp Med 1985; 161: 366–77
   PubMedGoogle Scholar